Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

130
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
130
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

97
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
97
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

213
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
213
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

197
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
197
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

157
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
157
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

141
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Encircled by stone.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026
Same author

Erdheim-Chester Disease: A Diagnostic Challenge.

Cureus·2026
Same author

Nutritional Composition of Commercially Sourced Meat from Two Anatomical Locations Under Regenerative and Intensive Production Systems.

Foods (Basel, Switzerland)·2026
Same author

Sleep Habits, Physical Exercise, and Social Media Use and Their Influence on Perceptions of Physical and Mental Health-Case Study at a Higher Education Institution in Portugal.

Healthcare (Basel, Switzerland)·2026
Same author

Applied Dynamic System Theory for Coordination Assessment of Whole-Body Center of Mass During Different Countermovements.

Sensors (Basel, Switzerland)·2026
Same author

Lung Carcinoids-Time to Change Practices.

Current oncology (Toronto, Ont.)·2026

Related Experiment Video

Updated: Nov 10, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

329

Linear scleroderma en coup de sabre - a different clinical presentation.

Miguel Vieira Martins1, Isabel Azevedo1, Carlos Rodrigues1

  • 1Centro Hospitalar Universitário Cova da Beira.

Acta Reumatologica Portuguesa
|April 6, 2021
PubMed
Summary
This summary is machine-generated.

Linear scleroderma en coup de sabre (LSeCS) is a rare autoimmune condition. Early diagnosis and treatment of LSeCS, especially with neurological symptoms like seizures, are crucial for favorable outcomes.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.5K
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.7K

Related Experiment Videos

Last Updated: Nov 10, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

329
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.5K
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.7K

Area of Science:

  • Dermatology
  • Neurology
  • Pediatric Rheumatology

Background:

  • Localized scleroderma (LoS) is a rare autoimmune condition affecting skin and underlying tissues.
  • Linear scleroderma en coup de sabre (LSeCS) is a subtype of LoS characterized by head lesions.
  • Neurological involvement, including seizures, occurs in up to 4% of LSeCS cases, often preceded by cutaneous manifestations.

Observation:

  • A case study of an 11-year-old boy with early-onset seizures and subsequent diagnosis of LSeCS is presented.
  • The patient developed a midline frontoparietal lesion with alopecia and hypopigmentation.
  • A 10-year follow-up revealed a favorable outcome for the patient.

Findings:

  • LSeCS is most commonly diagnosed in children and adolescents.
  • Meticulous examination of the face and scalp is essential for LSeCS diagnosis.
  • Neurological abnormalities in conjunction with head lesions warrant suspicion for LSeCS.

Implications:

  • Prompt diagnosis and management of LSeCS are vital, particularly in pediatric cases with neurological symptoms.
  • The primary treatment for LSeCS involves methotrexate and corticosteroids.
  • Increased clinical awareness of LSeCS is needed to ensure timely intervention and improve patient prognosis.